News for AVISA DIAGNOSTICS INC (FOGCD)

PARAMUS, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- Epygenix Therapeutics, a clinical-stage biopharmaceutical company developing drugs for rare and...

Toronto, Ontario-- Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... | December 6, 2021

VANCOUVER, BC, Dec. 6, 2021 /CNW/ - The following issues have been halted by IIROC: Company: Avisa Diagnostics Inc. CSE Symbol: AVBT All Issues: Yes

SANTA FE, N.M. and MALVERN, Pa., Nov. 24, 2021 -- Avisa Diagnostics Inc. , a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection... | November 24, 2021

SANTA FE, N.M. and MALVERN, Pa., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company

Experienced Industry pulmonologist brings decades of respiratory experience...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., Aug. 25, 2021 (GLOBE...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., Aug. 20, 2021 (GLOBE...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., July 12, 2021 (GLOBE...

Financial executive with strong public company experience joins growing Avisa team SANTA FE, N.M., June 22, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics

Toronto, Ontario - June 16, 2021 (Newsfile Corp.) (Investorideas.com Newswire) The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its ma...